metaPreg - Nefazodone during pregnancy

Nefazodone updated on 10-20-2025

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	0.49 [0.14, 1.72]	0%	2 studies	30,656	55	not evaluable	ROB	-
Major congenital malformations	0.49 [0.14, 1.72]	0%	2 studies	30,656	55	not evaluable	ROB	-
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions	8.37 [0.32, 219.24]	-	1 study	9	2	not evaluable	ROB	-
Hide endpoints reported in only one study ...